Assessment of Dyslipidemic Patients' Knowledge, Quality of Life, and Adherence

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Dyslipidemias
Interventions
BEHAVIORAL

Pharmaceutical care plan

"The design of the intervention was based on a stepwise approach to address the following point in each participant: set priorities for patient care, assessment of patient's educational needs, and development of a comprehensive and achievable pharmaceutical care plan.~The participants will be educated about their illness and informed about the proper use of their medication in a structured manner (it involved the following items: dyslipidemia as a disease, complications, who therapy reduces its risk and complications, goal of therapy). Behavioral modifications will involve the following: physical exercise, diet, smoking cessation. Patients will obtain this information verbally and provided in a written manner through a brochure that design for this study."

Trial Locations (1)

12221

Al-Rasheed University College, Baghdad

All Listed Sponsors
lead

Al-Rasheed University College

OTHER

NCT04319029 - Assessment of Dyslipidemic Patients' Knowledge, Quality of Life, and Adherence | Biotech Hunter | Biotech Hunter